ProQR Therapeutics stock rating reiterated at Market Outperform by Citizens
PositiveFinancial Markets

ProQR Therapeutics has received a positive stock rating from Citizens, who reiterated their 'Market Outperform' stance. This endorsement is significant as it reflects confidence in ProQR's potential for growth and success in the biotech sector, which could attract more investors and boost the company's market presence.
— Curated by the World Pulse Now AI Editorial System









